Showing results (101-110 of 129) with videos related to
Sort By:
Pageof 13
JCO Precision Oncology|June 12, 2026
Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTOBrian W Labadie, Aleksandar Obradovic, Alexander G Raufi, et al.Cell|February 1, 2024
SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasionGiuseppe Leuzzi, Alessandro Vasciaveo, Angelo Taglialatela, et al.Nature|September 10, 2025
Neuronal activity-dependent mechanisms of small cell lung cancer pathogenesisSolomiia Savchuk, Kaylee M Gentry, Wengang Wang, et al.Cancer Cell|June 16, 2023
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunityPatricia Ho, Johannes C Melms, Meri Rogava, et al.Science Advances|March 11, 2026
Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axisBruno Beernaert, Rose L Jady-Clark, Parin Shah, et al.Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Integrative Genomic, Transcriptomic, and Microbiome Profiles of Colon Cancer by Ancestry Provide Insights into Molecular DistinctionsMelissa Kramer, Pascal Belleau, Sofia C Tortora, et al.Nature Medicine|June 24, 2020
A single-cell landscape of high-grade serous ovarian cancerBenjamin Izar, Itay Tirosh, Elizabeth H Stover, et al.Nature|October 5, 2022
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesisAveline Filliol, Yoshinobu Saito, Ajay Nair, et al.Nature Medicine|March 5, 2021
Transcriptional mediators of treatment resistance in lethal prostate cancerMeng Xiao He, Michael S Cuoco, Jett Crowdis, et al.Nature Medicine|May 4, 2021
Evolution of delayed resistance to immunotherapy in a melanoma responderDavid Liu, Jia-Ren Lin, Emily J Robitschek, et al.Pageof 13